Navigating Key Differences in Therapeutic Antibody Patent Protection Strategies Between the United States and Europe

Many of today's top-selling drugs worldwide are therapeutic antibodies thus antibody-related inventions can be extremely valuable. Developing antibody therapeutics requires significant resources and time, so it is paramount to develop a robust patent strategy to protect that investment, prevent reverse-engineering, and minimize design-arounds.